Monika Davare’s lab focuses on overcoming the therapeutic bottleneck in rare but aggressive pediatric and adult cancers. Davare will share her latest research — and talk about her personal career path – in the Alliance for Visible Diversity in Science Keynote at Research Week.
Monika Davare, Ph.D.
Tuesday, May 1, 4 to 5 p.m.
Davare is an assistant professor of pediatrics in the OHSU School of Medicine. Her research was recognized in 2017 with a Biomedical Innovation Program Award in the drug discovery track. The award is given by the Oregon Clinical and Translational Research Institute.
In a paper published recently in Clinical Cancer Research, Davare and colleagues provided the first example of successful therapeutic intervention with targeted therapy to overcome crizotinib resistance in a ROS1-rearranged cancer.